Payer and manufacturer perspectives on the role of quality measures in outcomes-based contracts

Background: In traditional payment models between payers and pharmaceutical manufacturers, discounts and rebates are tied to volume of medications sold. Under outcomes-based contracts (OBCs), a subset of value-based contracts, payment is directly linked to achievement of mutually agreed upon performance benchmarks or defined outcomes, and payments can be negotiated based on improved patient outcomes from successful use of drugs.
Source: Research in Social and Administrative Pharmacy - Category: Pharmaceuticals Authors: Source Type: research